PL1979407T3 - Solubizacja i ukierunkowane dostarczanie leków samoorganizującymi się polimerami amfifilowymi - Google Patents

Solubizacja i ukierunkowane dostarczanie leków samoorganizującymi się polimerami amfifilowymi

Info

Publication number
PL1979407T3
PL1979407T3 PL06733750T PL06733750T PL1979407T3 PL 1979407 T3 PL1979407 T3 PL 1979407T3 PL 06733750 T PL06733750 T PL 06733750T PL 06733750 T PL06733750 T PL 06733750T PL 1979407 T3 PL1979407 T3 PL 1979407T3
Authority
PL
Poland
Prior art keywords
solubilization
drugs
self
targeted delivery
amphiphilic polymers
Prior art date
Application number
PL06733750T
Other languages
English (en)
Inventor
Anil Diwan
Ann Louise Onton
Jayant G Tatake
Original Assignee
Allexcel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allexcel Inc filed Critical Allexcel Inc
Publication of PL1979407T3 publication Critical patent/PL1979407T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/34—Introducing sulfur atoms or sulfur-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G75/00—Macromolecular compounds obtained by reactions forming a linkage containing sulfur with or without nitrogen, oxygen, or carbon in the main chain of the macromolecule
    • C08G75/02—Polythioethers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Peptides Or Proteins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
PL06733750T 2006-01-19 2006-01-19 Solubizacja i ukierunkowane dostarczanie leków samoorganizującymi się polimerami amfifilowymi PL1979407T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2006/001820 WO2007084126A1 (en) 2006-01-19 2006-01-19 Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
EP06733750.1A EP1979407B1 (en) 2006-01-19 2006-01-19 Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers

Publications (1)

Publication Number Publication Date
PL1979407T3 true PL1979407T3 (pl) 2015-03-31

Family

ID=38287941

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06733750T PL1979407T3 (pl) 2006-01-19 2006-01-19 Solubizacja i ukierunkowane dostarczanie leków samoorganizującymi się polimerami amfifilowymi

Country Status (20)

Country Link
US (1) US8173764B2 (pl)
EP (1) EP1979407B1 (pl)
JP (1) JP5027157B2 (pl)
KR (1) KR101263057B1 (pl)
CN (1) CN101400730B (pl)
AP (1) AP2570A (pl)
AU (1) AU2006336311B2 (pl)
BR (1) BRPI0621291A2 (pl)
CA (1) CA2637560C (pl)
CY (1) CY1115715T1 (pl)
DK (1) DK1979407T5 (pl)
EA (1) EA025295B1 (pl)
ES (1) ES2523431T3 (pl)
IL (2) IL192869A (pl)
NO (1) NO338835B1 (pl)
NZ (1) NZ570484A (pl)
PL (1) PL1979407T3 (pl)
PT (1) PT1979407E (pl)
SI (1) SI1979407T1 (pl)
WO (1) WO2007084126A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897170B2 (en) * 2006-08-25 2011-03-01 Boston Scientific Scimed, Inc. Medical devices having improved mechanical performance
BRPI0719561A2 (pt) * 2007-01-22 2013-01-29 Allexcell Inc polÍmeros anfifÍlicos de automontagem como agentes antivirais
AU2007356525B2 (en) * 2007-07-19 2014-07-17 Allexcel, Inc. Self-assembling amphiphilic polymers as anticancer agents
WO2010039496A2 (en) 2008-09-23 2010-04-08 The Regents Of The University Of California Nanocarriers for drug delivery
WO2010038747A1 (ja) * 2008-09-30 2010-04-08 国立大学法人大阪大学 親水性材料、医用材料および薬剤徐放材料
KR100987693B1 (ko) 2008-10-20 2010-10-13 서울대학교산학협력단 폴리(에틸렌 글리콜)-ｂ-[폴리(Ｌ-세린)-ｇ-폴리(Ｄ,Ｌ-락티드)]의 블록공중합체 및 이를 이용한 약물전달체용 나노입자의 제조 방법
US9801371B2 (en) 2010-11-10 2017-10-31 Battelle Memorial Institute Self-assembling polymer particle release system
US8496946B2 (en) 2011-03-10 2013-07-30 International Business Machines Corporation Antimicrobial hydrogels, methods of preparation thereof, and articles therefrom
US9642916B2 (en) 2012-12-12 2017-05-09 The Regents Of The University Of California Porphyrin modified telodendrimers
CN103254442B (zh) * 2013-04-28 2015-01-14 天津大学 二硫键键接的聚酯梳型接枝共聚物及其制备方法和应用
US10780175B2 (en) 2015-04-18 2020-09-22 The Texas A&M University System Polymer systems and their applications in diagnostics and drug delivery
WO2017193294A1 (zh) * 2016-05-10 2017-11-16 苏州大学张家港工业技术研究院 基于聚氨基酸的功能性生物可降解纳米粒子的制备方法
CN110392583B (zh) 2016-09-15 2023-01-03 加利福尼亚大学董事会 改进的杂化的末端树枝状聚合物
EP3577179B1 (en) 2017-01-31 2024-06-19 The Regents of The University of California Multi-arm block-copolymers for multifunctional self-assembled systems
JP7620321B2 (ja) 2018-08-31 2025-01-23 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア シアニンベースをベースとするテロデンドリマー及び癌治療のための使用
CN110423355B (zh) * 2019-08-29 2021-09-14 武汉轻工大学 羧甲基化莲藕多糖-曲古霉素a轭合物的制备方法
CN113082219B (zh) * 2021-04-07 2023-02-17 中国科学院大学温州研究院(温州生物材料与工程研究所) 一种基于π-π作用的疏水药物的增溶方法
WO2022271183A1 (en) * 2021-06-25 2022-12-29 Allexcel Inc. Self-assembling amphphlic polymers as anti-covid-19 agents
CN120981506A (zh) * 2023-03-30 2025-11-18 柏林自由大学 异多价聚合物及其抗病毒应用
CN120938965B (zh) * 2025-10-10 2026-02-03 浙江大学医学院附属第一医院(浙江省第一医院) 纳米金担载ns9283靶向长效镇痛药物及制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5319006A (en) * 1992-11-23 1994-06-07 Arco Chemical Technology, L.P. Preparation of polyesters from polyethers by an ester-insertion process
CA2226299A1 (en) * 1995-08-11 1997-02-27 Dendritech, Inc. Hyper comb-branched polymer conjugates
KR0180334B1 (ko) 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
DE19726186A1 (de) * 1997-06-20 1998-12-24 Boehringer Ingelheim Int Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen
ATE275977T1 (de) 1998-04-13 2004-10-15 Massachusetts Inst Technology Kamm-polymere zur regelung der zelloberflächenwechselwirkung
US6162877A (en) * 1998-12-04 2000-12-19 Hercules Incorporated Hydrophobically modified comb copolymers
EP1063254A1 (de) 1999-06-25 2000-12-27 Technische Uni München, Klinikum rechts der Isar, Inst. für Experiment. Onkoligie und Therapieforschung Copolymere für den Transport von Nukleinsäuren in die Zelle
DE19942302A1 (de) * 1999-09-04 2001-03-08 Beiersdorf Ag Sulfonierte Kammpolymere mit ausgewähltem Lithium/Natrium-Verhältnis und Zubereitungen, insbesondere haarkosmetische Zubereitungen auf der Grundlage von solchen sulfonierten Kammpolymeren
US6521736B2 (en) 2000-09-15 2003-02-18 University Of Massachusetts Amphiphilic polymeric materials
TWI246524B (en) 2001-01-19 2006-01-01 Shearwater Corp Multi-arm block copolymers as drug delivery vehicles
EP1465598A4 (en) 2001-12-21 2006-12-20 David S Soane USE OF OLIGOMERS AND POLYMERS FOR THE SOLUBILIZATION, STABILIZATION AND SUPPLY OF MEDICAMENTS
US7018655B2 (en) * 2002-03-18 2006-03-28 Labopharm, Inc. Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions
GB0221942D0 (en) 2002-09-20 2002-10-30 Univ Strathclyde Drug delivery
WO2006113666A2 (en) 2005-04-19 2006-10-26 Massachusetts Institute Of Technology Amphiphilic polymers and methods of use thereof
DK2171088T3 (en) * 2007-06-19 2016-01-25 Stratos Genomics Inc Nucleic acid sequencing in a high yield by expansion

Also Published As

Publication number Publication date
IL192869A0 (en) 2009-02-11
AP2008004573A0 (en) 2008-08-31
EP1979407A1 (en) 2008-10-15
IL225205A (en) 2017-03-30
WO2007084126A1 (en) 2007-07-26
EA200801729A1 (ru) 2009-02-27
NO338835B1 (no) 2016-10-24
JP5027157B2 (ja) 2012-09-19
KR101263057B1 (ko) 2013-05-09
SI1979407T1 (sl) 2015-01-30
EA025295B1 (ru) 2016-12-30
AU2006336311A1 (en) 2007-07-26
KR20080098373A (ko) 2008-11-07
HK1127490A1 (en) 2009-09-25
BRPI0621291A2 (pt) 2011-12-06
US20100260743A1 (en) 2010-10-14
CA2637560A1 (en) 2007-07-26
CA2637560C (en) 2013-11-26
NO20083573L (no) 2008-10-17
NZ570484A (en) 2011-02-25
AP2570A (en) 2013-01-23
IL192869A (en) 2013-04-30
EP1979407A4 (en) 2010-05-26
CN101400730B (zh) 2012-10-17
DK1979407T3 (en) 2014-11-03
DK1979407T5 (en) 2014-12-01
EP1979407B1 (en) 2014-08-06
JP2009528394A (ja) 2009-08-06
CN101400730A (zh) 2009-04-01
PT1979407E (pt) 2014-10-16
US8173764B2 (en) 2012-05-08
AU2006336311B2 (en) 2013-01-24
ES2523431T3 (es) 2014-11-25
CY1115715T1 (el) 2017-01-25

Similar Documents

Publication Publication Date Title
IL192869A0 (en) Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
IL276157A (en) Pharmaceutical preparations and methods for transferring them related to them
EP2516502A4 (en) BIODEGRADABLE BLOCK COPOLYMERS FOR ACTIVATING COMPOSITION AND RELATED METHODS
EP2516504A4 (en) BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPY AND AGGREGATE EXTRACTION AND THE METHOD THEREOF
EP2157919A4 (en) ENDOSCOPIC RELEASE DEVICES AND METHOD
IL211954A0 (en) Long term drug delivery devices with polyurethane-based polymers and their manufacture
SMT201900633T1 (it) Metodi e composizioni per rilascio prolungato di farmaci
EP3323405C0 (en) SYSTEM AND METHOD FOR DISPENSING MEDICATION
IL213376A (en) Stomach paused system for drug release Zalaplon and its uses
ZA200808114B (en) Formulations of low dose non-steroidal anti-inflammatory drugs and betacyclodextrin
IL192990A0 (en) Methods and compositions of targeted drug development
PL2052011T3 (pl) Nakierowany środek terapeutyczny będący dendrymerem polilizynowym
ZA200900423B (en) Methods and medicaments for administration of ibuprofen
EP2281576A4 (en) POLYMERS MICRES WITH ACTIVE TARGETING AND A CAPACITATED ACTIVE SUBSTANCE AND A CAPACITATED MEDICAL COMPOSITION
EP2643009A4 (en) COMPOSITION FOR THE RELEASE OF BIODEGRADABLE ACTIVE SUBSTANCES
ZA200804207B (en) Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
EP1977766A4 (en) DRUG SUPPLY MATERIAL
ZA200807058B (en) Solubilization and targeted devilery of drugs with self-assembling amphiphilic polymers
EP2023935A4 (en) METHOD FOR THE ADMINISTRATIVE MEDICINE
EP1993591A4 (en) TARGETED RELEASE OF PHARMACEUTICAL COMPOUNDS
ZA200603256B (en) Microsphere of two anti-tubercular drugs and biodegradable polymer administered by inhalation alone or combined with oral route, and process thereof
HK1129070A (en) Delivery device having self-assembling dendritic polymers and method of use thereof
HK1160002A (en) Long term drug delivery devices with polyurethane-based polymers and their manufacture
ZA201005951B (en) Controlled release drug delivery systems and pharmaceutical compositions formed therewith
AU2013260661A1 (en) Polysaccharide gel compositions and methods for sustained delivery of drugs